Issued Patents All Time
Showing 1–12 of 12 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12054781 | Detection of tumor-derived DNA in cerebrospinal fluid | Kenneth W. Kinzler, Bert Vogelstein, Yuxuan Wang, Luis Diaz, Nickolas Papadopoulos | 2024-08-06 |
| 11525163 | Papanicolaou test for ovarian and endometrial cancers | Isaac A. Kinde, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis Diaz +1 more | 2022-12-13 |
| 11306364 | TERT promoter mutations in gliomas and a subset of tumors | Hai Yan, Bert Vogelstein, Nickolas Papadopoulos, Kenneth W. Kinzler, Yuchen Jiao +3 more | 2022-04-19 |
| 10711310 | Tert promoter mutations in gliomas and a subset of tumors | Hai Yan, Bert Vogelstein, Nickolas Papadopoulos, Kenneth W. Kinzler, Yuchen Jiao +3 more | 2020-07-14 |
| 10619217 | Oligodendroglioma drive genes | Bert Vogelstein, Kenneth W. Kinzler, Nishant Agrawal, Nickolas Papadopoulos, Darell Bigner +2 more | 2020-04-14 |
| 10174384 | Use of the ZMIZ1 marker in directing treatment and predicting survival in cancer | Dimitrios Mathios, Michael Lim, Patrick Ha, Taeyoung Hwang, Chul-Kee Park | 2019-01-08 |
| 9873917 | Oligodendroglioma drive genes | Bert Vogelstein, Kenneth W. Kinzler, Nishant Agrawal, Nickolas Papadopoulos, Darell Bigner +2 more | 2018-01-23 |
| 9572843 | Combination bacteriolytic therapy for the treatment of tumors | Long Dang, Kenneth W. Kinzler, Bert Vogelstein | 2017-02-21 |
| 8691186 | Imaging infection with compounds that bind to thymidine kinase | Martin G. Pomper, Catherine A. Foss, Shibin Zhou, Kenneth W. Kinzler, Bert Vogelstein | 2014-04-08 |
| 8613917 | Combination bacteriolytic therapy for the treatment of tumors | Long Dang, Kenneth W. Kinzler, Bert Vogelstein | 2013-12-24 |
| 8273326 | Imaging infection with compounds that bind to thymidine kinase | Martin G. Pomper, Catherine A. Foss, Shibin Zhou, Kenneth W. Kinzler, Bert Vogelstein | 2012-09-25 |
| 8007782 | Combination bacteriolytic therapy for the treatment of tumors | Long Dang, Kenneth W. Kinzler, Bert Vogelstein | 2011-08-30 |